key: cord-0721971-rhqktad2
authors: Lesage, Sarah; Chazal, Maxime; Beauclair, Guillaume; Batalie, Damien; Couderc, Elodie; Lescure, Aurianne; Del Nery, Elaine; Tangy, Frédéric; Martin, Annette; Manel, Nicolas; Jouvenet, Nolwenn
title: Discovery of genes that modulate flavivirus replication in an interferon-dependent manner
date: 2021-08-11
journal: bioRxiv
DOI: 10.1101/2021.07.20.453077
sha: 0bf6e3c22fed82699c22e89f651dbe2543affecc
doc_id: 721971
cord_uid: rhqktad2

Establishment of the interferon (IFN)-mediated antiviral state provides a crucial initial line of defense against viral infection. Numerous genes that contribute to this antiviral state remain to be identified. Using a loss-of-function strategy, we screened an original library of 1156 siRNAs targeting 386 individual curated human genes in stimulated microglial cells infected with Zika virus (ZIKV), an emerging RNA virus that belongs to the flavivirus genus. The screen recovered twenty-one potential host proteins that modulate ZIKV replication in an IFN-dependent manner, including the previously known IFITM3 and LY6E. Further characterization contributed to delineate the spectrum of action of these genes towards other pathogenic RNA viruses, including Hepatitis C virus and SARS-CoV-2. Our data revealed that APOL3 acts as a proviral factor for ZIKV and several other related and unrelated RNA viruses. In addition, we showed that MTA2, a chromatin remodeling factor, possesses potent flavivirus-specific antiviral functions. Our work identified previously unrecognized genes that modulate the replication of RNA viruses in an IFN-dependent way, opening new perspectives to target weakness points in the life cycle of these viruses.

Establishment of the interferon (IFN)-mediated antiviral state provides a crucial initial line of defense 24 against viral infection. Numerous genes that contribute to this antiviral state remain to be identified.

Using a loss-of-function strategy, we screened an original library of 1156 siRNAs targeting 386 26 individual curated human genes in stimulated microglial cells infected with Zika virus (ZIKV), an 27 emerging RNA virus that belongs to the flavivirus genus. The screen recovered twenty-one potential 28 host proteins that modulate ZIKV replication in an IFN-dependent manner, including the previously 29 known IFITM3 and LY6E. Further characterization contributed to delineate the spectrum of action of 30 these genes towards other pathogenic RNA viruses, including Hepatitis C virus and SARS-CoV-2. Our 31 data revealed that APOL3 acts as a proviral factor for ZIKV and several other related and unrelated 32 RNA viruses. In addition, we showed that MTA2, a chromatin remodeling factor, possesses potent

Viruses are high on the list of global public health concerns, as illustrated by recent epidemics 38 caused by Ebola, Zika (ZIKV) and Nipah viruses, as well as by the ongoing SARS-CoV-2 pandemic.

The vast majority of these emerging RNA viruses have zoonotic origins and have recently crossed host 40 species barrier [1] . In order to establish itself in a host species, one of the first and most restrictive 41 barriers that a virus needs to overcome is the antiviral innate immune system. This response has evolved in the presence of siRNAs targeting IFNAR1, IFN signaling was neutralized and the level of infection 110 was almost rescued to the level of non-treated cells (Fig. S1A ). In cells silenced for IFITM3 expression, 111 the number of infected cells was partly restored to the level of non-treated cells (Fig. S1A ). Such partial 112 rescue was expected since the antiviral state requires the concerted action of numerous ISGs [21] . These 113 data also revealed that IFITM3 is a potent anti-ZIKV ISG in microglial cells.

We scaled up the experiment by screening an arrayed library containing 1158 siRNAs targeting 386 115 human genes (Table S1 ). These genes were selected based on a gene signature defined by clustering and 116 correlation of expression with MX1, a well-described ISG, in a dataset of gene expression in primary 117 human CD4 + T cells (Cerboni et al., in preparation) . 36% of the identified genes overlapped with 118 previous ISG libraries [21, 22] , ensuring that the screen would be simultaneously capable of identifying 119 expected positive hits and find new genes of interest. To overcome potential off-target effect and a 120 limited efficacy of transcript knockdown, each gene was targeted by 3 different siRNAs. Numerous 121 siRNAs targeting IFNAR1 and IFNAR2 were used as positive controls. Negative controls were non-122 targeting siRNAs. Transfection efficiency was evaluated using siRNAs against KIF11, a protein 123 essential for cell survival [23] . The same experimental protocol than in small-scale experiments was 124 applied (Fig. 1A) . Three images were acquired per condition with an INCell2200 automated wide-field 125 system. The mean cell count and the percentages of infected cells were extracted from quantification.

The screen was performed in duplicate.

For quality control purposes, we first compared the number of cells in each well in the 2 replicates.

We observed an expected distribution of the number of cells in 3 fields with a median close to 1000 129 cells per well for the two replicates (Fig. S1B ). The number of cells per condition was slightly higher in 130 the first replicate than in the second one. However, the R² coefficient of determination of the linear 131 regression was close to 0.7 (Fig. S1C) , indicating that the reproducibility of the experiment was correct.

As expected [23] , siRNAs against KIF11 were lethal, validating the transfection protocol ( Fig. S1B , C).

The 2 screens were first analyzed by taking into consideration the intensity of the E signal per cell. The 134 number of cells expressing the viral protein E distributed as predicted, with a median close to 15% for 135 the 2 screens (Fig. S1D ). As expected from pilot experiments (Fig. S1A ), siRNAs targeting IFNAR-1 136 and -2 rescued ZIKV replication in IFN-treated cells (Fig. S1D, E) . The reproducibility of the infection 137 status of the cells between the 2 screens, with a R² greater than 0.8, was satisfactory (Fig. S1E) . The 138 data were then analysis using a second approach that identified infected cells based on the E expression 139 independently of the intensity of the signal. The 2 methods identified similar number of infected cells 140 (Fig. S1F ). Results were expressed as robust Z-scores for each siRNA (Fig. 1B, C) . Genes were defined 141 as hits when at least two over three of their robust Z scores had an absolute value superior to 2 in the 142 two replicates, in at least one of the analysis. The screen identified 9 antiviral genes and 12 proviral ones 143 (Fig. 1D ). Some hits were previously described as modulators of ZIKV replication, such as IFITM3 144 [19, 20] and LY6E [24] , thus validating our loss-of-function screening approach. These twenty-one hits 145 were selected for further validation.

IFNa2-treated HMC3 cells were transfected with pool of 3 siRNAs against each candidate, and not 147 by individual ones as in the primary screening. Twenty-four hours post-ZIKV infection, intracellular 148 viral RNA production was quantified by RT-qPCR and the number of cells positive for the viral protein 149 E was assessed by flow cytometry analysis. The same samples were used to assess the efficacy of the 150 siRNAs. RT-qPCR analyses revealed that 15 out of the 21 siRNA pools were reducing the expression 151 of their respective targets in IFN-treated cells (Fig. S1G ). mRNAs levels of C1R, XCL1, GBP3, NADK,

C22orf39 and RUBCN were below the detection limit in IFNa2-treated HMC3 (Fig. S1G) . These genes 153 were thus excluded from further anaysis. Reduced expression of IRF9, IFITM3, MTA2 and GPD2 154 significantly enhanced both viral RNA yield and the number of infected cells as compared to IFNa2-155 treated cells transfected with control siRNAs (Fig. 1E and F to histone deacetylase activity [27] . Ten times more viral RNA copies were recovered in cells silenced 160 for MTA2 expression than in control cells (Fig. 1E ) and four times more cells were positive for the viral 161 E protein (Fig. 1F ). These effects were comparable to the ones induced by IFNAR1 silencing (Fig. 1E 162 and F). Transfection with siRNA against the other 3 antiviral candidates (PXK, NMI and IFI16) had no 163 significant effect on ZIKV replication in these assays ( Fig. 1E and 1F ), suggesting that they may be 164 false positive candidates. Reducing the expression of LY6E, ISG15 and APOL3 significantly decreased 165 both viral RNA production and the number of cells positive for the E protein ( Fig. 1G and 1H) , validating 166 the pro-viral activities of these 3 candidates. The pro-viral function of USP18 and NAPA were also 167 validated since reducing their expression led to a significant reduction of the number of infected cells 168 as compared to control cells (Fig. 1H ). Reduced expression of ISG20 or CCND3 had no significant 169 effect on ZIKV replication ( Fig. 1G and 1H ). IRF2, which was identified as a pro-viral hit by the screen, 

We next explored the ability of 10 candidate genes (IRF9, IFITM3, MTA2, GPD2, LY6E, USP18, 176 ISG15, APOL3, GBP3 and NAPA) to modulate the replication of two other pathogenic RNA viruses:

Hepatitis C virus (HCV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which 178 are, respectively, related and unrelated to ZIKV. HCV, which is a member of the Hepacivirus genus 179 within the Flaviviridae family, has a tropism for hepatocytes. SARS-CoV-2 belongs to the 180 Coronaviridae family and has a tropism for pneumocytes and enterocytes.

HCV infections were conducted in hepatoma Huh-7.5 cells, which support well viral replication [28] .

182 Huh-7.5 cells are unable to induce IFN expression since they express an inactive form of RIG-I [29] but 183 they possess an intact JAK/STAT pathway and do thus respond to IFN treatment [30] . RT-qPCR 184 analyses revealed that 8 out 10 siRNA pools efficiently reduced the expression of their respective targets 185 in stimulated Huh-7.5 cells (Fig. S2A ). Since LY6E and APOL3 mRNA levels were under the limit of 186 detection of the assays in IFNa2-treated Huh-7.5 cells (Fig. S2A ), they were excluded from further 187 analysis. As expected, reduced expression of IFNAR and IRF9 significantly enhanced HCV RNA yield 188 and the production of infectious particles in IFNa2-treated Huh-7.5 cells, as compared to control cells 189 ( Fig. 2A, B) . Reduced expression of IFITM3, MTA2 or GPD2, which significantly enhanced ZIKV 190 replication in HCM3 cells (Fig. 1E , F), did not affect HCV RNA production ( Fig. 2A) . However, 191 surprisingly, their reduced expression triggered a significant decrease in the release of infectious HCV 192 particles as compared to control cells (Fig. 2B ). This suggests that they might favor a late stage of HCV 

These results suggest that some genes are broadly-acting IFN effectors, such as IRF9 and ISG15.

Other genes appeared to have evolve modulatory function toward a specific viral family or genus, such 213 as APOL3 and MTA2. Finally, some genes, including LY6E, IFITM3 and GPD2, exhibited opposite 

LY6E, ISG15 and APOL3 exhibited significant pro-ZIKV activities in stimulated cells, as measured 219 by cell-associated viral RNA levels ( Fig. 1G ) and percentage of E-positive cells (Fig. 1H ). Among these 220 3 genes, APOL3 is the least described and was thus selected for further characterization. APOL3 is one 221 of the 6 members of the apolipoprotein L gene family. Apolipoproteins are typically associated with the 222 transport of lipids in the organism and were originally described as members of the high-density 223 lipoprotein family, which are involved in cholesterol transport [36] . In human cells, the expression of 224 the 6 members of the APOL gene family are up-regulated by multiple pro-inflammatory signaling 225 molecules, including IFNs and TNFa [36, 37] . These regulations suggest a link between APOL proteins 226 and the innate immune system. siRNA targeting APOL2, APOL3, APOL4, APOL5 and APOL6 were 227 present in our library (Table S1 ). Among these 5 APOLs, only APOL3 was identified as a facilitator of 228 ZIKV infection by our screen (Fig. 1) . We decided to test the ability of APOL1 to modulate ZIKV 229 replication since it was previously identified in a high-throughput overexpression screen as an ISG able 

Analysis of mRNA levels of APOL1 and APOL3 revealed that the genes were upregulated by 232 IFNa2 treatment in HMC3 cells (Fig. 3A) . Both genes thus qualify as genuine ISGs in these cells. The

implication of APOL1 and APOL3 in ZIKV replication was investigated using loss-of-function 234 approaches. siRNA-silencing reduced the levels of APOL1 and APOL3 mRNAs by ~80% and ~85%, 235 respectively, when compared to cells expressing scrambled control siRNAs (Fig. 3B) . USP18, which is 236 known to negatively regulates the JAK-STAT pathway, and, as such, is a broad-spectrum pro-viral 237 factor [38], was identified during our screen as a pro-ZIKV candidate in HMC3 cells (Fig. 1D ). Since 238 its pro-ZIKV function was validated in our system (Fig. 1H ), siRNAs specific for USP18 were used as 

Extinction of APOL1 and APOL3 resulted in a modest, but reproducible, decrease in the number of E-247 positive HMC3 cells pre-treated with IFNa2 (Fig. 3C) . A pro-viral effect of APOL1 was also observed 248 in unstimulated cells (Fig. 3C ). The efficacy of the siRNAs against APOL1 and USP18 were further 249 validated by Western Blot analysis using specific antibodies (Fig. 3D ). APOL3 levels in cell lysates 250 could not be assessed due to the lack of available antibodies. Levels of expression of the viral proteins 251 NS5 and E were slightly decreased in IFNa2-cells expressing reduced levels of APOL1 or APOL3, 252 compared to control cells ( Fig 3D) . Together, these results suggest that ZIKV requires the expression of 253 APOL1 and APOL3 for optimal replication in HMC3 cells. By contrast to APOL1, the pro-viral action of APOL3 was dependent on IFNa2-treatment.

To ensure that the APOL1-and APOL3-mediated modulation of viral replication was not restricted 

We tested whether APOL1 and APOL3 were active against DENV-2 or WNV, which are mosquito- Recent data revealed that APOL1 and APOL3 play a role in lipid metabolism in podocytes and, more 293 specifically, in the regulation of the production of phosphatidylinositol-4-phosphate (PI(4)P), via an 294 indirect interaction with the PI4KB kinase [41] . PI(4)P is involved in Golgi secretory functions by 295 facilitating the recruitment of proteins that promote vesicular transport [42] . PI(4)P is also essential for 296 the establishment of efficient viral replication via the formation of membranes which serve as platforms 297 for the production of viral RNA [43, 44] . APOL1 and/or APOL3 could thus impact ZIKV replication via 298 their ability to regulate the production of PI(4)P. To test this hypothesis, we first assessed APOL1 and 299 APOL3 localization in HMC3 cells. In the absence of specific antibodies for APOL1 and APOL3 

APOL1-GFP was also detected in vesicle-like structures whose identity could not be established ( Fig.   306 4A, white arrow). They may represent lipid droplets or fragmented Golgi. The localization of APOL1-307 GFP and GFP-APOL3 could not be investigated in ZIKV-infected cells since we observed that 308 transfection rendered cells non-permissive to viral infection.

We then performed experiments with a well-characterized PI4KB kinase inhibitor that decreases 310 PI(4)P expression [46] . We first analyzed by immunofluorescence the intensity of the PI(4)P signal in 311 cells treated for 24 h with different concentrations of the drug in HCM3 cells. The presence of the PI4KB 312 inhibitor triggered a dose-dependent decrease of the PI(4)P signal (Fig. 4C) , suggesting that the drug is 313 efficient in HMC3 cells. We then infected cells with ZIKV in the presence of different concentration of 314 the inhibitor. Since the effect of APOL3 on ZIKV replication is dependent on IFNa2 (Fig. 3) , the 315 analysis was also performed in stimulated cells. Coxsackie B3 virus (CVB3), an enterovirus that 316 replicates in a PI(4)P-dependent manner, was used as a positive control since its replication is sensitive 317 to the drug [47] . As negative controls, we used cells infected with WNV, whose replication is not 318 affected by the PI4KB inhibitor [48] . As previously shown in HeLa cells [47], a dose-dependent 319 reduction of the number of cells positive for the CVB3 viral protein 1 (VP1) was triggered by the 320 inhibitor treatment (Fig. 4D ). As shown previously in monkey cells [48] , WNV replication was 321 unaffected by the PI4KB inhibitor in HCM3 cells (Fig. 4D ). ZIKV protein production was not sensitive 322 to the treatment with the PI4KB kinase inhibitor, independently of the presence of IFNa2 (Fig. 4D ).

These experiments suggest that the pro-viral activities of APOL1 and APOL3 are not related to their 324 interaction with PI4KB or PI(4)P in microglial cells.

MTA2 was identified in our screen as a gene with potent anti-ZIKV activities (Fig. 1) . MTA2 shows 328 a very broad expression pattern and is strongly expressed in many tissues. It belongs to the NuRD 329 complex, which establishes transcriptional modulation of a number of target genes in vertebrates, 330 invertebrates and fungi [27] . Since its function has, so far, not been linked to viral infection, we decided 331 to investigate its potential antiviral activities further. To ensure that the MTA2-mediated inhibition of 

5A and 5C), indicating that MTA2 is not an ISG in these cells.

Assessment of viral replication by RT-qPCR revealed that cell-associated viral RNA yields were 342 significantly higher in IFN-treated HMC3 cells silenced for MTA2 expression, as compared to controls 343 cells (Fig. 5E ). This is in line with previous results (Fig. 1E ). Cytometry analysis using anti-E antibodies 344 confirmed that MTA2 anti-ZIKV activities were dependent on the presence of IFN in HCM3 cells (Fig. 345 5F). Since MTA2 is not an ISG in HMC3 cells (Fig. 5A) , these results suggest that MTA2 may require 346 an active IFN signaling to exert its anti-ZIKV activities in these cells. As in HMC3 cells, reduced 347 expression of MTA2 triggered a significant increase of intracellular viral RNA production in stimulated 348 Huh-7 cells (Fig. 5G ). Reducing MTA2 expression had a more pronounced effect on the percentage of 349 infected cells that reducing IFNAR1 expression in stimulated Huh-7 cells (Fig. 5H ). Albeit to a lesser 350 extent than in stimulated cells, MTA2 anti-ZIKV activity was also observed in non-stimulated Huh-7 351 cells by flow cytometry and RT-qPCR analysis ( Fig. 5G and H) .

The effect of MTA2 on viral protein production was further assessed by Western blot analysis using expressing reduced levels of MTA2 or IFNAR1, as compared to control cells ( Fig. 5I and 5J) . In 357 agreement with the flow cytometry analysis (Fig. 5H) , MTA2 anti-ZIKV activity was less dependent of 358 IFN-treatment in Huh-7 cells than in HMC3 cells ( Fig. 5I and 5J ). As observed in flow cytometry 359 analysis (Fig. 5H) , MTA2 effect on viral protein production was more potent than the one of IFNAR1 360 in stimulated Huh-7 cells (Fig. 5J ).

These results represent the first evidence of the ability of MTA2 to restrict the replication of any 362 virus.

We tested whether MTA2 was active against WNV and YFV in Huh-7 cells, which are permissive 366 to these 2 flaviviruses. As in previous experiments, higher MOIs were used in the presence of IFNa2.

Cytometry analysis revealed that MTA2 silencing significantly enhanced the replication of these 2 368 flaviviruses in an-IFN dependent manner ( Fig. 6A and 6B) , indicating that MTA2 antiviral activity is 369 broader that ZIKV. We then tested the effect of MTA2 silencing on the replication of VSV and MeV in 370 Huh-7 cells. Reduced expression of MTA2 decreased the number of cells infected with VSV and MeV 371 ( Fig. 6C and 6D) , independently of the IFN stimulation. This is consistent with the pro-HCV activity of 372 MTA2, as measured by titration in stimulated Huh-7.5 cells (Fig. 2B) 

We validated the role of 5 hits as genes contributing to an optimal ZIKV replication in stimulated 405 HMC3 cells using RT-qPCR and flow cytometry analysis: LY6E, USP18, ISG15, APOL3 and NAPA.

The identification of LY6E as a gene enhancing ZIKV replication was expected, since it was previously 407 shown to promote the internalization of flaviviruses in U2OS human osteosarcoma cells [24] 

Experiments performed on cells infected with HCV or SARS-CoV-2 contributed to delineate the 422 spectrum of action of a selection of the screen hits. Our data illustrate once again that some ISGs have 423 virus-specific antiviral activities [63] . For instance, we found that ZIKV, but not the related HCV, was 424 sensitive to IFITM3 expression, confirming (HCV) and extending (ZIKV) recently reported data 425 [20, 64] . Our data also confirm that some ISGs exert opposite effect on different viruses. For instance, 

Our results identified APOL3 and APOL1 as ISGs required for optimal ZIKV replication in HMC3 431 cells. The proviral activity of APOL1 was less dependent on IFN that the one of APOL3, which suggest 432 that both proteins act via different mechanisms. Reduced expression of APOL1 and APOL3 also 433 restricted the replication of WNV and DENV in stimulated HMC3 cells. In line with these findings, 434 over-expression of APOL1 was previously reported to increase YFV replication in Huh-7 cells [21] .

VSV replication was highly reduced in the absence of one of these 2 genes. APOL1 has been reported 436 to act as an antiviral ISG in the context of infection with alphaviruses (Sindbis virus and Venezuelan equine encephalitis virus) and human parainfluenza virus [21, 67] . Its over-expression also inhibits HIV-438 1 infection in monocytes [68] . Thus, APOL1 and APOL3 seem to behave like pro-or anti-viral ISG 439 depending on the virus, or have no obvious role (HCV). In line with our data on flaviviruses, a recent 440 report found that overexpression of APOL1 promoted infection with ZIKV and DENV-2, confirming a 441 proviral role for this factor [69] . However in this study, an increase of ZIKV, DENV-2 and HCV 442 replication was also reported in Huh-7.5 cells expressing siRNAs targeting APOL1 and APOL3 in the 443 absence of IFN treatment [69], yielding conflicting data that will deserve further investigation.

From our data, we formulated the hypothesis that APOL1 and APOL3 pro-viral activities could be 445 linked to their ability to bind to anionic phospholipids, including several phosphoinositides, in particular In the first analysis, data were processed using a software developed internally at the Biophenics 569 platform. For hit identification, the robust Z-score method was used under the assumption that most 570 siRNAs are inactive against ZIKV and can serve as controls [83, 84] . Raw values were log-transformed 571 for cell count only to make the data more symmetric and close to normal distribution. In order to correct A gene was identified as a 'hit', if the RZ-score was < -2 or > 2 pointing in the same direction for 2 582 siRNAs targeting the same gene in both screens. Final values in the hit table correspond to the RZ-score 583 of the second strongest siRNA. In the second analysis, data were process using an homemade script and 584 CellProfiler [85] . Nucleus and viral assembly sites detected by the E signal were counted. As in the first 585 analysis, rZ-Score and percentages of infected cells were quantified. Considering that each gene was 586 targeted by three individual siRNA, genes were clusterized as hits, if at least two over three of their 587 robust Z score absolute value were superior to 2. Genes were defined as hits when they were identified 588 in at least one of the analysis. Table S2 . Antiviral  effect  IRF9  IFITM3  MTA2  PXK  GPD2  C1R  XCL1  NMI  IFI16   Proviral  effect  LY6E  USP18  ISG15  APOL3  GBP3  NAPA  NADK  ISG20  IRF2 

Human viruses: 689 discovery and emergence

Stimulation of Innate Immunity by Host and Viral RNAs

693 3. Schoggins JW. Recent advances in antiviral interferon-stimulated gene biology

Interferome 696 v2.0: an updated database of annotated interferon-regulated genes

Combinatorial flexibility of cytokine function during human T helper cell 700 differentiation

Parsing the 702 interferon transcriptional network and its disease associations

Interferon-Stimulated Genes: A Complex 705 Web of Host Defenses

The continued threat of emerging flaviviruses

Usutu virus: an emerging flavivirus in 710

The emergence of Zika virus and its new clinical 712 syndromes

Zika virus 714 infects human testicular tissue and germ cells

717 Characterization of a Novel Murine Model to Study Zika Virus

A 723 novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and 724 host inflammatory immune responses

An 727 evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction

Axl Mediates ZIKA Virus Entry in Human Glial Cells and Modulates Innate Immune 731 Responses

Role of microglia in the 733 dissemination of Zika virus from mother to fetal brain

Zika virus infected primary 736 microglia impairs NPCs proliferation and differentiation

Inhibit Zika Virus Replication

Zika 741 virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells

A 744 diverse range of gene products are effectors of the type I interferon antiviral response

Systematic identification of type I 747 and type II interferon-induced antiviral factors

Identification of cytoskeleton-associated proteins essential for lysosomal stability and 750 survival of human cancer cells

Flavivirus internalization is regulated by a size-dependent 753 endocytic pathway

Interferon Regulatory Factor 9 Structure and Regulation

IFITM proteins-cellular inhibitors of viral 758 entry

Highly permissive cell lines for subgenomic and 762 genomic hepatitis C virus RNA replication

Regulating 764 intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication 765 through a cellular RNA helicase, RIG-I

Hepatitis C virus-mediated enhancement of 768 microRNA miR-373 impairs the JAK/STAT signaling pathway

Protease 18 Promotes Hepatitis C Virus Production by Increasing Viral Infectivity. Mediators 772 of Inflammation

Silencing of 774 USP18 Potentiates the Antiviral Activity of Interferon Against Hepatitis C Virus Infection

Hepatitis C virus reveals a novel early control in acute immune response

ISG15, a 780 ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: 781 implications for chronic infection and response to treatment

LY6E 784 impairs coronavirus fusion and confers immune control of viral disease

The function of apolipoproteins L

The apolipoprotein L gene 789 cluster has emerged recently in evolution and is expressed in human vascular tissue

UBP43 is a 792 novel regulator of interferon signaling independent of its ISG15 isopeptidase activity

Zika Virus Infection of the Human Glomerular Cells: Implications for 795 Viral Reservoirs and Renal Pathogenesis

A 798 Molecularly Cloned Schwarz Strain of Measles Virus Vaccine Induces Strong Immune 799 Responses in Macaques and Transgenic Mice

Terminal Variants May Trigger Kidney Disease through Interference with APOL3 803 Control of Actomyosin

The Great Escape: how phosphatidylinositol 4-kinases and PI4P promote 805 vesicle exit from the Golgi (and drive cancer)

Strating JR, van Kuppeveld FJ. Viral rewiring of cellular lipid metabolism to create 811 membranous replication compartments

Conserved role for Gga proteins 814 in phosphatidylinositol 4-kinase localization to the trans-Golgi network

Design and Structural Characterization of Potent and Selective Inhibitors of 818 Phosphatidylinositol 4 Kinase IIIβ

Viral 821 reorganization of the secretory pathway generates distinct organelles for RNA replication

virus replication requires fatty acid synthesis but is independent on 825 phosphatidylinositol-4-phosphate lipids

Identification of five 828 interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections

Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C 832 virus replication

A 837 CRISPR screen identifies IFI6 as an ER-resident interferon effector that blocks flavivirus 838 replication

PARP12 suppresses Zika virus 840 infection through PARP-dependent degradation of NS1 and NS3 viral proteins

C19orf66 interrupts Zika virus 843 replication by inducing lysosomal degradation of viral NS3. PLOS Neglected Tropical 844 Diseases

A Viperin Mutant Bearing the K358R 846 Substitution Lost its Anti-ZIKA Virus Activity

Cell-type-and region-specific 849 restriction of neurotropic flavivirus infection by viperin

ISG15 in antiviral immunity and beyond

Multiple functions of USP18

Mechanistic insights into the 856 SNARE complex disassembly

UVRAG is required for 861 virus entry through combinatorial interaction with the class C-Vps complex and SNAREs

Glycerol 864 phosphate shuttle enzyme GPD2 regulates macrophage inflammatory responses

replication are broadly conserved antiviral properties of IFITMs

Viral Evasion Strategies in Type I IFN Signaling -A 875 Summary of Recent Developments

The innate immune factor apolipoprotein L1 880 restricts HIV-1 infection

Basal expression of interferon regulatory factor 1 drives intrinsic hepatocyte resistance to 883 multiple RNA viruses

Defining how viruses 885 manipulate lipid phosphoinositides through activation of PI4P kinases to mediate viral 886 replication

The Endoplasmic Reticulum 888 Provides the Membrane Platform for Biogenesis of the Flavivirus Replication Complex

Toxoplasma Effector 891 Recruits the Mi-2/NuRD Complex to Repress STAT1 Transcription and Block IFN-γ

Nusinzon I, Horvath CM. Interferon-stimulated transcription and innate antiviral 895 immunity require deacetylase activity and histone deacetylase 1

Histone 898 deacetylase inhibitors suppress IFNα-induced up-regulation of promyelocytic leukemia 899 protein

A 901 conditionally immortalized human podocyte cell line demonstrating nephrin and podocin 902 expression

Growth of human hepatoma 904 cells lines with differentiated functions in chemically defined medium

Syncytia 907 formation by SARS-CoV-2-infected cells

RIG-I 910 Recognizes the 5' Region of Dengue and Zika Virus Genomes

NS2 913 proteins of GB virus B and hepatitis C virus share common protease activities and membrane 914 topologies

Production of 916 infectious hepatitis C virus in tissue culture from a cloned viral genome

Cell culture 919 adaptation of hepatitis C virus and in vivo viability of an adapted variant

Differential 922 regulation of the Wnt/beta-catenin pathway by hepatitis C virus recombinants expressing core 923 from various genotypes

Statistical practice in high-925 throughput screening data analysis

Statistical Methods for Analysis of High-Throughput RNA Interference Screens

CellProfiler 3.0: Next-generation image processing for biology

Reverse 933 genetic system, genetically stable reporter viruses and packaged subgenomic replicon based 934 on a Brazilian Zika virus isolate

936 Rescue of the 1947 Zika Virus Prototype Strain with a Cytomegalovirus Promoter-Driven 937 cDNA

GAPDH mRNA and siRNA-NT without IFN. (E, G) Cell-associated viral RNA was quantified by 1013

RT-qPCR and expressed as genome equivalents (GE) per µg of total cellular RNA. (F, H) Number of 1014 infected cells was assessed by staining of viral protein E and flow cytometry analysis. (I, J) Cells were 1015 treated with IFNa2 (200U/mL) or left untreated, transfected with the indicated siRNAs pools and 1016 subjected to Western blotting analysis with antibodies against the indicated proteins. Data are means ± 1017 SD of three independent experiments

Effect of reduced expression of MTA2 on the replication of YFV, WNV

200U/mL) for 24 hours and infected with WNV (A) or YFV (B) for 24 hours, at the MOIs indicted in 1022 the MM section. The percentages of the cells positive for viral protein Env was determined by flow 1023 cytometric analysis. HMC3 cells were transfected with the indicated siRNAs pool

1025 at the MOIs indicted in the MM section. The percentages of the cells positive for viral protein G or GFP 1026 were determined by flow cytometric analysis. Data are expressed relatively to the siRNA NT control of 1027 each experiment. Data are means ± SD of three or four independent experiments

Quality control and reproducibility of the screens. (A) HMC3 cells were transfected with 1033 either pool of 3 siRNAs against IFNAR or IFITM3 or non-targeting (NT) siRNAs, treated with IFNa2 1034 (1000U/mL) for 24 hours and infected with ZIKV PF13 at a MOI of 7 PFU/cell for 24 hours

B) Distribution of the "number of cells per 3 fields" parameter for each screen

The values of the control wells (cells transfected with siRNA targeting KIF11) are shown in dark gray

Representation of the number of cells per 3 fields of screen 1 as a function of the screen 2. The green 1039 line represents the linear regression as compared to the expected perfect correlation

The 1041 values of the control conditions (cells transfected with siRNAs targeting IFNAR1 or IFNAR2) are 1042 shown in dark grey. (E) Representation of the percentage of infected cells per well of screen 1 as a 1043 function of screen 2, as identified by the first analysis. The green line represents the linear regression as 1044 compared to the expected perfect correlation (dotted black line). (F) Representation of the percentage 1045 of infected cells per well in the analysis 1 as a function of analysis 2

quantified by RT-qPCR analysis in HMC3 cells or podocytes treated or not with IFNa2 (200U/mL) for 979 24 hours and expressed as copy numbers per µg of total cellular RNA. HMC3 cells (B) or podocytes (F) 

were transfected with pool of 3 siRNAs targeting APOL1, APOL3 and USP18 mRNAs or with non-981 targeting (NT) control siRNAs. The relative amounts of APOL1, APOL3 and USP18 mRNAs were 982 determined by RT-qPCR analysis and were normalized to that of GAPDH mRNA. They are expressed 983 as compared to abundance relative to cells transfected with control NT siRNAs. HMC3 cells (C) or amounts of MTA2 and IFNAR1 mRNAs were determined by RT-qPCR analysis and normalized to that with non-targeting (NT) control siRNAs. The relative abundances of the mRNAs of the candidate genes 1048 were determined by RT-qPCR analysis and were normalized with respect to GAPDH mRNA level.

They are expressed relatively to abundance in cells transfected with NT siRNAs set at 1. Data are means 1050 ± SD of three or four independent experiments. ND: not determined due to mRNA levels below assay 1051 threshold. The samples are the same than in Fig. 1E